Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study

BACKGROUND: No liquid biomarkers are approved in renal cell carcinoma (RCC), making early detection of recurrence in surgically treated nonmetastatic (M0) patients dependent on radiological imaging. Urine- and plasma free glycosaminoglycan profiles—or free GAGomes—are promising biomarkers reflective...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Francesco, Dabestani, Saeed, Bratulic, Sinisa, Limeta, Angelo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Stierner, Ulrika, Nielsen, Jens, Lundstam, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Kidney Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334826/
https://www.ncbi.nlm.nih.gov/pubmed/35911082
http://dx.doi.org/10.1016/j.euros.2022.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334826/
https://www.ncbi.nlm.nih.gov/pubmed/35911082
http://dx.doi.org/10.1016/j.euros.2022.06.003

Ejemplares similares